Consulting, Research, Analysis
Rupa K. Bose is a consultant, specializing in international business. She is also the author of several reports and a book, India Business Checklists, published by John Wiley & Sons in 2009.
An independent consultant, she has undertaken a wide range of assignments, including acting as President of Bioenterprises Asia, a life-sciences consulting company, and Chief Financial Officer of Lynk Biotechnologies, a start-up drug design company. Earlier, Rupa headed Indian equity research and strategy for Merrill Lynch (during this time AsiaMoney ranked her amongst the “Region’s Best Analysts” in three consecutive years) and was senior equities analyst covering petrochemicals and pharmaceuticals for Paribas in Singapore. Before that, she worked with SRI International, producing a range of industry reports, and also worked on development projects for a number of leading MNCs.
Her advisory career started with the US firm Business International as the head of South Asia. During this time she ran BI’s India Country Program (a CEO peer group for leading Indian industrialists) and authored a series of book length reports on corporate strategy in South Asia. She also assisted an array of MNC clients with entry strategies for India, Pakistan, Sri Lanka, Bangladesh, and Burma.
Rupa has a BA (Hons) Economics (University of Delhi), a Post Graduate Diploma in Business Administration (Indian Institute of Management, Ahmedabad), and an MBA (Anderson Graduate School of Management, UCLA). She is a member of the Beta Gamma Sigma Society and Mensa.